Regeneron Pharmaceuticals Inc (REGN)
Operating profit margin
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 3,688,200 | 3,840,900 | 3,831,000 | 3,990,700 | 4,051,200 | 4,082,700 | 4,029,600 | 4,281,000 | 4,545,700 | 4,558,400 | 4,848,800 | 5,132,600 | 6,456,900 | 7,080,400 | 9,120,700 | 8,946,800 | 7,474,100 | 6,680,000 | 3,989,200 | 3,576,600 |
| Revenue (ttm) | US$ in thousands | 14,247,800 | 14,214,200 | 14,085,700 | 14,202,000 | 13,847,100 | 13,489,100 | 13,100,100 | 13,117,200 | 13,097,300 | 12,670,800 | 12,369,900 | 12,172,900 | 13,710,200 | 14,226,800 | 16,508,100 | 16,071,700 | 13,542,900 | 12,384,100 | 9,197,600 | 8,497,100 |
| Operating profit margin | 25.89% | 27.02% | 27.20% | 28.10% | 29.26% | 30.27% | 30.76% | 32.64% | 34.71% | 35.98% | 39.20% | 42.16% | 47.10% | 49.77% | 55.25% | 55.67% | 55.19% | 53.94% | 43.37% | 42.09% |
September 30, 2025 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $3,688,200K ÷ $14,247,800K
= 25.89%
Peer comparison
Sep 30, 2025
Company name
Symbol
Operating profit margin
Regeneron Pharmaceuticals Inc
REGN
25.89%
Arrowhead Pharmaceuticals Inc
ARWR
11.86%
Biomarin Pharmaceutical Inc
BMRN
19.89%
See also:
Regeneron Pharmaceuticals Inc Operating Profit Margin (Quarterly Data)